Lamotrigine-Associated Skin Rash
The risk factors and methods of minimizing the occurrence of serious rash during treatment with lamotrigine (LTG) were evaluated by an international panel of experts and by review of published and unpublished reports.
Saved in:
| Main Author: | J Gordon Millichap |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pediatric Neurology Briefs Publishers
1999-08-01
|
| Series: | Pediatric Neurology Briefs |
| Subjects: | |
| Online Access: | https://www.pediatricneurologybriefs.com/articles/2046 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lamotrigine-Related Skin Rash
by: J. Jokubaitė, et al.
Published: (2023-12-01) -
A description of sodium valproate, lamotrigine and levetiracetam consumption in the Western Cape public sector
by: Nicole Keuler, et al.
Published: (2022-06-01) -
Allergic skin rash with lamotrigine and concomitant valproate therapy: evidence for an increased risk Rash cutâneo com lamotrigina e concomitante uso de valproato: evidências de maior risco
by: L. M. Li, et al.
Published: (1996-03-01) -
Effect of Lamotrigine on the EEG
by: J Gordon Millichap
Published: (2003-08-01) -
Effect of Lamotrigine on Refractory Epilepsy: Clinical Outcomes and EEG Changes
by: Li Z, et al.
Published: (2025-01-01)